Xenon Pharmaceuticals【XENE】株式ニュース

名称	銘柄コード	市場	種別
Xenon Pharmaceuticals Inc	XENE	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.00	0.00%	38.80	17:09:48

始値	安値	高値	終値	前日終値
				38.80

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/10	05:35	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/10	05:09	EDGAR2	Form 8-K - Current report
2024/5/10	05:01	GLOBE	Xenon Pharmaceuticals Reports First Quarter 2024 Financial..
2024/5/09	05:01	GLOBE	Xenon Pharmaceuticals to Present at the BofA Securities..
2024/5/08	05:01	GLOBE	Xenon Pharmaceuticals to Present at the 2024 RBC Capital..
2024/5/03	05:01	GLOBE	Xenon Pharmaceuticals Announces Conference Call and Webcast..
2024/4/16	21:30	GLOBE	Xenon Pharmaceuticals Showcases XEN1101 at the American..
2024/4/05	05:01	GLOBE	Xenon Pharmaceuticals to Present at the 23rd Annual Needham..
2024/3/13	05:01	GLOBE	Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS..
2024/3/09	08:47	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/09	07:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/09	07:28	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/09	07:27	EDGAR2	Form 8-K - Current report
2024/3/08	09:04	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/08	09:03	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/06	06:01	GLOBE	Xenon Pharmaceuticals to Present at Leerink Partners Global..
2024/3/01	06:10	EDGAR2	Form 8-K - Current report
2024/3/01	06:01	GLOBE	Xenon Pharmaceuticals Reports Fourth Quarter and Full Year..
2024/2/23	06:01	GLOBE	Xenon Pharmaceuticals Announces Conference Call and Webcast..
2024/2/14	23:12	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/08	22:00	GLOBE	Xenon Pharmaceuticals Outlines Key Milestone Opportunities..
2024/1/03	22:30	GLOBE	Xenon Pharmaceuticals to Present at the 42nd Annual J.P...
2024/1/03	06:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/05	06:16	GLOBE	Xenon Pharmaceuticals Announces Closing of $345.0 Million..
2023/12/03	02:01	GLOBE	Xenon Pharmaceuticals Provides Updates on Neurology Pipeline..
2023/12/01	06:18	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/12/01	06:15	EDGAR2	Form 8-K - Current report
2023/11/30	12:51	GLOBE	Xenon Pharmaceuticals Announces Pricing of Upsized $300.0..
2023/11/30	07:05	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/30	06:03	GLOBE	Xenon Pharmaceuticals Announces Proposed Public Offering
2023/11/27	21:03	EDGAR2	Form 8-K - Current report
2023/11/27	21:00	GLOBE	Xenon Pharmaceuticals Announces Topline Results from Phase 2..
2023/11/10	06:06	EDGAR2	Form 8-K - Current report
2023/11/10	06:03	GLOBE	Xenon Pharmaceuticals Provides Update on Partnered Program..
2023/11/09	06:36	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09	06:11	EDGAR2	Form 8-K - Current report
2023/11/09	06:01	GLOBE	Xenon Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/02	05:01	GLOBE	Xenon Pharmaceuticals Announces Conference Call and Webcast..
2023/10/10	05:15	GLOBE	Xenon Pharmaceuticals Announces Publication of Results from..
2023/10/06	21:30	GLOBE	Xenon Pharmaceuticals to Present at Jefferies Inaugural..
2023/9/15	05:01	GLOBE	Xenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual..
2023/9/13	05:30	GLOBE	Xenon Pharmaceuticals Announces Upcoming Investor Webinar..
2023/9/04	21:30	GLOBE	Xenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at..
2023/9/01	05:01	GLOBE	Xenon Pharmaceuticals to Present at the Wells Fargo 2023..
2023/8/11	08:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/11	08:00	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/8/11	07:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/11	07:40	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/8/10	05:38	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/10	05:16	EDGAR2	Form 8-K - Current report